|
|
Meibergdreef 59
Amsterdam, 1105 BA Netherlands
phone:+31 (0)20 566 8575
fax:+31 (0)20 566 9081
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.primagen.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Molecular diagnostic tests that have high, individualized predictive value. |
|
| Management |
| Dr. Bob van Gemen, CEO; Dr. Jos Rijntjes, CCO (Chief Commercial Officer); Drs. Gijs Vermeulen, Chief Financial Officer |
| |
|
|
| |
|
| Keywords |
| in vitro, diagnostics, metabolic, infectious, diseases, aids, cancer, HIVAIDS |
|
|
|
| Description |
|
Primagen designs, develops and commercializes molecular diagnostic tests that have high, individualized predictive value and improve the quality of life for patients suffering from life-threatening diseases, such as infections, AIDS and cancer. |
|
| Products / Services |
Primagen has two marketed molecular product lines. Primagen has developed a molecular test, Retina Mitox, to assess the mitochondrial DNA content of cells from blood or tissues.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members